Use of slamf1 as a biomarker in colorectal cancer

Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that differ from conventional T lymphocytes in having no antigen-specific receptors. ILCs […]

Use of cd160 as a biomarker in acute myeloid leukemia

Natural killer (NK) cells are innate cytotoxic lymphoid cells (ILCs) involved in the killing of infected and tumor cells. Several NK cell subsets have […]

Methods of treatment and diagnostic of pathological conditions

The present invention relates to a method for preventing or treating pathological conditions associated with intense stress such as Post-Traumatic […]

Bile salts bactosensor and use thereof for diagnostic and therapeutic

Bile salts are steroid acids derived from cholesterol in the liver, are released into the gastrointestinal tract to aid in digestion and are […]

Methods for detecting the presence of coronavirus-specific antibodies

Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The viral genome is 26–32 kilobases in length. In late December […]

Methods for discontinuing a treatment with a tyrosinekinase inhibitor

The present invention relates to a method for discontinuing a treatment with a TKI by determining the number and/or frequency of innate CD8(+) T-cells […]

Methods for diagnosing nasal intestinal type adenocarcinomas

The present invention relates to methods and compositions for the diagnostic and for the treatment of nasal intestinal type adenocarcinomas (ITAC). […]

New biomarkers for predicting antipsychotic treatment response in a

A fundamental shortcoming in the current treatment of schizophrenia is the lack of valid criteria to predict who will respond to antipsychotic […]

Methods of determining whether patients suffering from acute myeloid

Deciphering the impact of metabolic intervention on response to anticancer therapy represents a path toward improved clinical responses. Here, the […]

New biomarkers and targets for prognosis in patients with renal cell

Renal Cell Carcinoma (RCC) encompasses a heterogeneous group of cancers derived from renal tubular epithelial cells and has a worldwide mortality. […]